Weiwei L. Ma
Pinghu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Ex vivo pretreatment with venetoclax boosts the antileukemic efficacy of therapeutic γδ T cells in AML models.
Journal: The Journal of clinical investigation
Published: July 23, 2026
Bacteriological Profile and Antimicrobial Resistance in Intraoperative Purulent Samples From Acute Appendicitis: A 3-Year Retrospective Analysis.
Journal: ANZ journal of surgery
Published: September 09, 2025
Author Correction: PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia.
Journal: Nature cell biology
Published: August 19, 2025
Author Correction: SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming.
Journal: Nature cell biology
Published: August 11, 2025
IFN-γ induces hematopoietic stem cell myelopoiesis through Meis1 in tumor.
Journal: Stem cell research & therapy
Published: July 14, 2025
A ketogenesis-ferroptosis axis maintains leukemic stem cell survival and leukemia progression.
Journal: Cell stem cell
Published: June 24, 2025
Corrigendum to "HIF-2α 1 inhibition disrupts leukemia stem cell metabolism and impairs vascular microenvironment to enhance chronic myeloid leukemia treatment" [Cancer lett. 597 (2024) 217060].
Journal: Cancer letters
Published: January 01, 2025
STAT1 inhibition promotes oxidative stress to sustain leukemia stem cell maintenance.
Journal: Cellular signalling
Published: December 18, 2024
IFN alpha signaling drives hematopoietic stem cells malfunction under acute inflammation.
Journal: International immunopharmacology
Published: October 09, 2024
HIF-2α inhibition disrupts leukemia stem cell metabolism and impairs vascular microenvironment to enhance chronic myeloid leukemia treatment.
Journal: Cancer letters
Published: December 21, 2023
Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2.
Journal: Biology
Published: August 24, 2023
SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming.
Journal: Nature cell biology
Published: March 22, 2023
Last Updated: 09/26/2026